By Taylor Mixides (Drug Target Review)2023-06-01T16:00:10
Scientists have discovered that a vaccinated San Diego resident has produced antibodies that are effective against multiple variants of SARS-CoV-2, including Omicron. The research also identified three antibodies that can neutralise the virus, giving new insights into different binding mechanisms with the SARS-CoV-2 spike protein. The findings could help to ...
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-10T09:00:00Z
2026-07-10T06:15:00Z
Contributor Professor Donald E Ingber, By Drug Target Review
2026-07-09T12:00:00Z
2026-07-08T09:00:00Z
2026-07-07T12:00:00Z
2026-06-02T15:00:00
Sponsored by Danaher Life Sciences
2024-01-10T08:56:17
Sponsored by Leica Microsystems
2026-06-01T07:00:00
Contributor Dr Timothy O’Connor, By Drug Target Review
2024-05-07T13:11:19
Sponsored by BellBrook Labs
2024-01-10T08:23:16
Sponsored by BellBrook Labs
2024-02-01T11:52:50
Sponsored by Leica Microsystems
Site powered by Webvision Cloud